Fipamezole Hydrochloride

็›้…ธ้žๅธ•็พŽๅ”‘

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameFipamezole Hydrochloride
Drug Alias NameFipamezolum็›้…ธ่ฒๅธ•้บฆๅ”‘้žๅธ•็พŽๅ”‘็›้…ธ็›Fipamezol้žๅธ•็พŽๅ”‘ +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsHypotensionParkinson DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPortugalFrance +[4]ย 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypotensionParkinson DiseaseMultiple System Atrophy

Other Information

ATC CodeN/A
Related LinksN/A